Form 4: Xylem Inc. Director Earl R. Ellis Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Earl R. Ellis reports acquisition of 1,300 shares of Xylem Inc. common stock through restricted stock units.
Summary
- On May 13, 2025, Earl R. Ellis, a director of Xylem Inc., acquired 1,300 shares of common stock at a price of $126.93 per share.
- This acquisition was made through an award of restricted stock units (RSUs) under the Xylem 2011 Omnibus Incentive Plan.
- The RSUs are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.
- Ellis has elected to defer the settlement of the RSU award until separation from service.
- Following the transaction, Ellis beneficially owns 4,309 shares of Xylem Inc. common stock, which includes additional shares due to dividend reinvestment.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by a director. The acquisition itself can be seen as slightly positive, indicating confidence, but the document is primarily informational.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The reporting person has elected to defer the settlement of the RSU Award until Separation from Service.
Industry Context
This is a standard disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Comparison to Industry Standards
- Insider trading disclosures are a standard practice for publicly listed companies like Xylem Inc.
- Companies like Danaher (DHR) and Roper Technologies (ROP) also have similar insider trading disclosures when their executives or directors trade company stock.
- The reporting requirements and timelines are generally consistent across these companies, adhering to SEC regulations.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| February 24, 2016 | Xylem 2011 Omnibus Incentive Plan Amended and Restated |
| May 13, 2025 | Date of transaction: acquisition of 1,300 shares of common stock |
| May 14, 2025 | Date of signature for the Form 4 filing |
| 2026 Annual Meeting of Shareholders | RSUs are scheduled to vest in full on the trading day prior to this date |
Keywords
Xylem Inc., Director, Earl R. Ellis, Common Stock, Restricted Stock Units, Beneficial Ownership, Form 4, XYL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.